they also raise the possibility of adverse side effects of gm-csf therapy in patients whose malignant cells may be directly stimulated by this molecule and suggest a previously unanticipated role of gm-csf gene activation in the evolution of solid tumors and in the pathogenesis of myelofibrosis .
C0334227
malignant cells
C0001815
myelofibrosis